Literature DB >> 28251254

[Side effects of chemotherapy].

K Hauner1, P Maisch2, M Retz2.   

Abstract

Urologic tumors are frequently treated by multimodal therapeutic strategies with the consequence of an increasing number of adverse events. The most common chemotherapy-induced side effects are neutropenia, stomatitis, mucositis, diarrhea, and emesis. The efficacy of tumor therapy can be improved by good prophylaxis and standardized management of side effects.

Entities:  

Keywords:  Diarrhea; Emesis; Mucositis; Neutropenia; Stomatitis

Mesh：

Year:  2017        PMID： 28251254     DOI： 10.1007/s00120-017-0338-z

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  16 in total

Review 1.  Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Authors:  F Roila; J Herrstedt; M Aapro; R J Gralla; L H Einhorn; E Ballatori; E Bria; R A Clark-Snow; B T Espersen; P Feyer; S M Grunberg; P J Hesketh; K Jordan; M G Kris; E Maranzano; A Molassiotis; G Morrow; I Olver; B L Rapoport; C Rittenberg; M Saito; M Tonato; D Warr
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications.

Authors:  J Crawford; C Caserta; F Roila
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

3.  SEOM clinical guidelines for myeloid growth factors.

Authors:  José Muñoz Langa; Pere Gascón; Javier de Castro
Journal:  Clin Transl Oncol       Date:  2012-07       Impact factor: 3.405

Review 4.  International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.

Authors:  Karin Jordan; Richard Gralla; Franziska Jahn; Alex Molassiotis
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

5.  Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Department of Medicine; Department of Biostatistics and Computational Biology; Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston; Johns Hopkins University, Baltimore; University of Wisconsin Carbone Cancer Center; School of Medicine and Public Health; Madison; Fox Chase Cancer Center, Temple University Health System, Philadelphia; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis; Mayo Clinic, Rochester, MN; University Hospitals Case Medical Center, Seidman Cancer Center; Cleveland Clinic Taussig Cancer Institute; Both in Cleveland; University of Virginia Cancer Center, Charlottesville; Comprehensive Cancer Centers of Nevada, Las Vegas; Siteman Cancer Center, Washington University School of Medicine, St. Louis; NorthShore University Health System, Evanston, IL; University of Michigan Comprehensive Cancer Center, Ann Arbor; Rutgers Cancer Institute of New Jersey, New Brunswick.N Engl J Med. 2015 Aug 20;373(8):737-46. [Epub 2015 Aug 5]. doi: 10.1056/NEJMoa1503747.

Authors:  Eggener Scott
Journal:  Urol Oncol       Date:  2017-02-01       Impact factor: 3.498

6.  [Side effects of radiotherapy in the oral cavity].

Authors:  Wolfgang Dörr; Elke Dörr; Julia Haagen; Jörg T Hartmann; Dorothea Riesenbeck; Margret Schmidt; Knut A Grötz
Journal:  MMW Fortschr Med       Date:  2010-11-18

7.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

8.  The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Authors:  Rudolph M Navari; Cindy K Nagy; Sarah E Gray
Journal:  Support Care Cancer       Date:  2013-01-12       Impact factor: 3.603

9.  A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.

Authors:  M Aapro; H Rugo; G Rossi; G Rizzi; M E Borroni; I Bondarenko; T Sarosiek; C Oprean; S Cardona-Huerta; V Lorusso; M Karthaus; L Schwartzberg; S Grunberg
Journal:  Ann Oncol       Date:  2014-03-05       Impact factor: 32.976

10.  Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

Authors:  Nicholas D James; Matthew R Sydes; Noel W Clarke; Malcolm D Mason; David P Dearnaley; Melissa R Spears; Alastair W S Ritchie; Christopher C Parker; J Martin Russell; Gerhardt Attard; Johann de Bono; William Cross; Rob J Jones; George Thalmann; Claire Amos; David Matheson; Robin Millman; Mymoona Alzouebi; Sharon Beesley; Alison J Birtle; Susannah Brock; Richard Cathomas; Prabir Chakraborti; Simon Chowdhury; Audrey Cook; Tony Elliott; Joanna Gale; Stephanie Gibbs; John D Graham; John Hetherington; Robert Hughes; Robert Laing; Fiona McKinna; Duncan B McLaren; Joe M O'Sullivan; Omi Parikh; Clive Peedell; Andrew Protheroe; Angus J Robinson; Narayanan Srihari; Rajaguru Srinivasan; John Staffurth; Santhanam Sundar; Shaun Tolan; David Tsang; John Wagstaff; Mahesh K B Parmar
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321
View more
  8 in total

1.  Facile Synthesis of Multifunctional Magnetoplasmonic Au-MnO Hybrid Nanocomposites for Cancer Theranostics.

Authors:  Cong Tian; Zhe Tang; Yike Hou; Asim Mushtaq; Shafaq Naz; Zhangsen Yu; Jabeen Farheen; Muhammad Zubair Iqbal; Xiangdong Kong
Journal:  Nanomaterials (Basel)       Date:  2022-04-16       Impact factor: 5.719

2.  Combined Effects of Protocatechuic Acid and 5-Fluorouracil on p53 Gene Expression and Apoptosis in Gastric Adenocarcinoma Cells.

Authors:  Zahra Motamedi; Sayed Asadollah Amini; Elham Raeisi; Yves Lemoigne; Esfandiar Heidarian
Journal:  Turk J Pharm Sci       Date:  2020-12-23

3.  A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer.

Authors:  Danhui Ma; Yutian Zou; Yunxiang Chu; Zhengsheng Liu; Gaochao Liu; Jun Chu; Mengdi Li; Jiayu Wang; Shi-Yong Sun; Zhijie Chang
Journal:  Theranostics       Date:  2020-02-19       Impact factor: 11.556

Review 4.  Dietary Compounds for Targeting Prostate Cancer.

Authors:  Seungjin Noh; Eunseok Choi; Cho-Hyun Hwang; Ji Hoon Jung; Sung-Hoon Kim; Bonglee Kim
Journal:  Nutrients       Date:  2019-10-08       Impact factor: 5.717

5.  Clinical observations of bone marrow transfusion for promoting bone marrow reconstruction after chemotherapy for AIDS-related lymphoma.

Authors:  Yixuan Liu; Suhong Xie; Lei Li; Yanhui Si; Weiwei Zhang; Xin Liu; Lin Guo; Baochi Liu; Renquan Lu
Journal:  BMC Immunol       Date:  2021-01-28       Impact factor: 3.615

Review 6.  Metal Nanoparticles for Photodynamic Therapy: A Potential Treatment for Breast Cancer.

Authors:  Liang Shang; Xinglu Zhou; Jiarui Zhang; Yujie Shi; Lei Zhong
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

Review 7.  The Employment of Genera Vaccinium, Citrus, Olea, and Cynara Polyphenols for the Reduction of Selected Anti-Cancer Drug Side Effects.

Authors:  Jessica Maiuolo; Vincenzo Musolino; Micaela Gliozzi; Cristina Carresi; Francesca Oppedisano; Saverio Nucera; Federica Scarano; Miriam Scicchitano; Lorenza Guarnieri; Francesca Bosco; Roberta Macrì; Stefano Ruga; Antonio Cardamone; Anna Rita Coppoletta; Sara Ilari; Annachiara Mollace; Carolina Muscoli; Francesco Cognetti; Vincenzo Mollace
Journal:  Nutrients       Date:  2022-04-10       Impact factor: 6.706

Review 8.  Combination Anticancer Therapies Using Selected Phytochemicals.

Authors:  Wamidh H Talib; Dima Awajan; Reem Ali Hamed; Aya O Azzam; Asma Ismail Mahmod; Intisar Hadi Al-Yasari
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.